Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Barco reports non-financial support from Bayer HealthCare and Daiichi Sankyo, outside the submitted work.
Conflict of interest: Dr. Dartevelle has nothing to disclose.
Conflict of interest: Marion Delcroix has been investigator, speaker, consultant, or steering committee member for Actelion, Bayer, Eli Lilly, GlaxoSmithKline, MSD, and Pfizer; and has received research grants from Actelion.
Conflict of interest: Dr. Fadel has nothing to disclose.
Conflict of interest: Dr. Jenkins reports grants and personal fees from Bayer, personal fees from Actelion, outside the submitted work.
Conflict of interest: Nick Kim reports research support form Actelion, Bayer, J&J and Merck, and received lecture honoraria from Bayer
Conflict of interest: Frederikus Klok reports research grants from Bayer, Bristol-Myers Squibb, Boehringer-Ingelheim, MSD, Daiichi-Sankyo, Actelion, the Dutch thrombosis association and the Dutch Heart foundation
Conflict of interest: Stavros Konstantinides has received consultancy and lecture honoraria from Bayer HealthCare, Boehringer Ingelheim, Daiichi-Sankyo, and Pfizer -Bristol-Myers Squibb; payment for travel accommodation/meeting expenses from Bayer HealthCare; and institutional grants from Boehringer Ingelheim, Bayer HealthCare, and Daiichi-Sankyo.
Conflict of interest: Dr. Lang reports personal fees from MSD, grants and personal fees from AOPORphan Pharma, grants and personal fees from Actelion, outside the submitted work.
Conflict of interest: Dr. Madan has nothing to disclose.
Conflict of interest: Dr. Matsubara reports personal fees from Actelion Pharmaceuticals Japan, Ltd., personal fees from AOP Orphan Pharmaceuticals AG, personal fees from Bayer Yakuhin, Ltd., personal fees from Nippon Shinyaku, Co., Ltd., personal fees from Pfizer Japan, Inc., personal fees from Kaneka Medix Corporation, outside the submitted work.
Conflict of interest: Dr. Mayer reports personal fees from Actelion, personal fees from Bayer, personal fees from MSD, personal fees from Pfizer, outside the submitted work.
Conflict of interest: JPZ or her institution have received research, educational grants from Actelion, Merck, Bayer. JPZ served at advisory boards Actelion, J&J, Merck, Bayer, GSK
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018